A cloud-based artificial intelligence solution, powered by Intel® technology, will be launched in India, greatly reducing the screening burden on vitreoretinal surgeons. Sankara Eye Foundation in India and Singapore-based Leben Care are deploying this comprehensive retina risk assessment software-as-a-service platform in India, which uses deep learning to identify retinal conditions in a short span of time with the accuracy level of human doctors. Netra.AI can accurately identify diabetic retinopathy (DR) and has screened more than 3000 patients so far. | shorturl.at/wBHKN